MASIMO CORP

Delisted

CIK 937556fmd_1HCRQ08KS1C9TA3AQB1DPPGD2XManufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard

Coverage: Dec 30, 2007 to Apr 04, 2026, 69 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	713	790	858	938	1,144	1,239	2,036	1,276	1,395	1,527
Cost of revenue	235	268	283	309	401	431	977	510	601	582
Gross profit	478	522	575	629	743	808	1,059	766	794	945
Research and development	58	65	81	93	119	137	191	131	182	126
Selling, general and administrative	255	273	285	315	369	395	657	451	549	506
Total operating expenses	42	338	367	408	487	533	849	600	731	635
Operating income	436	184	208	221	256	276	210	166	63	310
Interest expense	3	1	1	0	0	0	26	47	41	33
Other non-operating income (expense)	(2)	2	6	13	8	(1)	(17)	(53)	(41)	(37)
Income before taxes	434	186	214	234	264	274	193	113	22	273
Income tax expense	122	61	20	38	23	45	50	5	6	65
Net income from continuing operations	311	125	194	196	240	230	144	108	16	208
Net income	311	125	194	196	240	230	144	82	(305)	(152)